课题基金 / 基金详情

项目摘要

项目成果

Sandor Gyorke的其他基金

相似基金

相关文献

中文摘要
翻译
摘要 心力衰竭(HF)一直是一个主要的卫生保健挑战。改变的心肌细胞钙信号是一种 这是心衰病理生理学的重要组成部分,在寻找新的有效治疗方法方面具有重要意义。 尽管在快速时间尺度上发生的钙依赖过程的阐明方面取得了进展,但机制 钙调节缓慢的心脏过程,包括对生理和病理的长期适应 对于压力,人们仍然知之甚少。这一进步的关键障碍是由于我们对 心肌细胞生物学的基本方面,包括蛋白质合成、加工的位置和机制 和送货。缺乏探测和跟踪较慢/较长时间的技术工具更是雪上加霜 活的心肌细胞中的分子过程。存储操作钙进入(SOCE),其中细胞内钙耗尽 存储促使细胞外钙进入胞浆,最近成为细胞外钙的重要组成部分 心肌细胞钙信号转导。SOCE是由基质相互作用分子(STIM1)介导的,一旦 感觉肌浆/内质网(SR/ER)钙耗竭,与肌膜钙相互作用并激活。 释放激活通道蛋白(ORAI1)。据报道,STIM1在适应不良中起关键作用 肥大。然而,STIM1促进肥厚的机制及其在适应性中的作用 肥大(运动性)仍有待阐明。最近,我们发现SOCE及其分子 机械定位于细胞对细胞接触部位,即插入盘(ID)。根据初步结果, 我们提出了一个新的假说,即SOCE通过促进局部的 在入侵检测系统的一个专用的mRNA池中合成蛋白质。事实上,正常心脏中的SOCE可能是最好的 调节以实现运动诱导的适应性肥大反应的“金发地带”。相比之下, SOCE的病理性失调可能被证明是有害的。具体地说,在疾病中SOCE过度活动可能 因此导致应激性心肌病(SCM)等现象。 在这项提议中,我们将使用尖端的细胞生理学和分子技术(包括超 分辨率显微镜、新的细胞报告系统)和新的遗传小鼠模型来测试这些 假设和确定关键的细胞微纳结构域,以及参与SOCE的分子步骤- 推动了心肌细胞的生长。我们还将研究以SOCE机制的关键组件为目标的可能性 (具体地说,STIM1L,STIM1的长剪接变体),介导适应性不良的肥大。为此,我们 提出以下具体目标:1)明确SOCE在适应性和非适应性肥厚中的作用。2) 确定SOCE调节肥厚的亚细胞和分子机制;以及3)定义 SOCE在应激诱导的肥厚性心脏病中的作用和机制。这些研究将产生新的 深入了解生理性和病理性肥厚的机制,并为 针对心脏结构和功能异常的基于机制的新疗法。
英文摘要
ABSTRACT Heart failure (HF) continuous to be a major health care challenge. Altered myocyte calcium (Ca) signaling is an essential part of the pathophysiology of HF and of critical relevance in the search for new effective therapies. Despite progress in the elucidation of Ca-dependent processes occurring on rapid time scales, mechanisms whereby Ca modulates slow cardiac processes, including long term adaptations to physiological and pathological stress, remain poorly understood. This critical barrier to progress is attributable to our poor understanding of foundational aspects of cardiomyocyte biology, including sites and mechanisms of protein synthesis, processing and delivery. This is compounded by the lack of technological tools for probing and tracking slower / long-lived molecular process in living myocytes. Store-operated Ca entry (SOCE), wherein depletion of intracellular Ca stores prompts extracellular Ca entry into the cytosol, has recently emerged as an important component of cardiomyocyte Ca signaling. SOCE is mediated by the stromal interaction molecule (STIM1), which, upon sensing sarco/endoplasmic reticulum (SR/ER) Ca depletion, interacts with and activates the sarcolemmal Ca- release activated channel protein (ORAI1). STIM1 has been reported to play a critical role in maladaptive hypertrophy. However, the mechanism whereby STIM1 contributes to hypertrophy and its role in adaptive hypertrophy (exercise-induced) remain to be elucidated. Recently, we discovered that SOCE and its molecular machinery are localized at the cell-to-cell contact sites, the intercalated discs (IDs). Based on preliminary results, we put forth a novel hypothesis that SOCE promotes myocyte longitudinal growth through facilitation of localized protein synthesis from a dedicated pool of mRNAs at the IDs. Indeed, SOCE in the normal heart may be optimally tuned to achieve a “Goldilocks zone” of adaptive hypertrophic response, as induced by exercise. In contrast, pathological dysregulation of SOCE may prove deleterious. Specifically, SOCE over-activity in disease may underlie maladaptive hypertrophy, thus leading to phenomena such as stress-induced cardiomyopathy (SCM). In this proposal, we will use cutting-edge cellular physiology and molecular techniques (including super- resolution microscopy, novel cellular reporter systems) and novel genetic mouse models to test these hypotheses and determine key cellular micro- and nanodomains, as well as molecular steps involved in SOCE- driven myocyte growth. We will also examine the possibility of targeting key components of the SOCE machinery (specifically, STIM1L, the long splice variant of STIM1) that mediate maladaptive hypertrophy. To this end, we propose the following specific aims: 1) Define the role of SOCE in adaptive and maladaptive hypertrophy. 2) Define subcellular and molecular mechanisms underlying modulation of hypertrophy by SOCE; and 3) Define the role and mechanism of SOCE in stress-induced hypertrophic cardiac disease. These studies will yield new insights into the mechanisms underlying physiological and pathological hypertrophy and provide a foundation for new mechanism-based therapies for abnormal cardiac structure and function.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ryanodine Receptor Channels in Heart Failure
  • 批准号:
    6897494
  • 项目类别:
  • 资助金额:
    $36.39万
  • 财政年份:
    2003
  • 负责人:
    Sandor Gyorke
  • 依托单位:
Abnormal intracellular calcium release in heart failure
  • 批准号:
    10298021
  • 项目类别:
  • 资助金额:
    $56.17万
  • 财政年份:
    2003
  • 负责人:
    Sandor Gyorke
  • 依托单位:
Ryanodine Receptor Channels in Heart Failure
  • 批准号:
    7079305
  • 项目类别:
  • 资助金额:
    $36.01万
  • 财政年份:
    2003
  • 负责人:
    Sandor Gyorke
  • 依托单位:
Ryanodine Receptor Channels in Heart Failure
  • 批准号:
    6999314
  • 项目类别:
  • 资助金额:
    $36.88万
  • 财政年份:
    2003
  • 负责人:
    Sandor Gyorke
  • 依托单位:
国内基金
海外基金
Journal of Integrative Plant Biology
  • 批准号:
    31024801
  • 项目类别:
    专项基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2010
  • 负责人:
    贺萍
  • 依托单位: